GlassScriptPhysician profile
Austin J Niu
NPI 1154947968
$3,115.71
in general payments reported to CMS, 2019-2025
14 companies · $2,539 in 2025
The $2,539 reported for 2025 was more than what 98% of Hospitalist providers received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $577 · 2025: $2,539.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,107 · Travel and Lodging: $8.90.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,106.81 |
| Travel and Lodging | $8.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $761.64 | 2024-2025 | Impella |
| Boston Scientific Corporation | $618.48 | 2024-2025 | Ekosonic, Farapulse, Avvigo Guidance System |
| Abbott Laboratories | $346.50 | 2024-2025 | Perclose Prostyle, Cardiomems, Navitor |
| Actelion Pharmaceuticals US, INC. | $308.89 | 2024-2025 | Opsumit, Uptravi |
| Bridgebio Pharma, INC. | $246.83 | 2025 | Attruby |
| Edwards Lifesciences Corporation | $222.28 | 2024-2025 | Sapien 3 Ultra Resilia |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $208.12 | 2024-2025 | Lifevest |
| Amgen INC. | $190.37 | 2024-2025 | Repatha, Repatha |
| Impulse Dynamics (USA) INC. | $44.69 | 2025 | Optimizer |
| Novartis Pharmaceuticals Corporation | $44.43 | 2025 | |
| Getinge USA Sales, LLC | $39.03 | 2025 | Vasoview Hemopro 2 |
| Procyrion, INC. | $38.94 | 2024 | |
| Cvrx, INC. | $28.38 | 2025 | Barostim Neo System |
| Heartflow, INC. | $17.13 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Austin Niu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.